Trial intelligence / Profile preview

Yiwei oral liquid for post-chemotherapy epigastric fullness syndrome

ChiCTR1900022047Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Mar 2019
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of Yiwei Oral Liquid in None (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: R-INVR Assessment Form. Planned start Mar 2019; status: not yet recruiting.

02

Drugs

Yiwei Oral Liquid

Beyond the preview

Go deeper on ChiCTR1900022047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call